Biotechnology

NKGen Biotech

NKGen Biotech released FY2024 Q4 earnings on October 8 (EST), actual revenue USD 0, actual EPS USD -0.737

NKGen Biotech released FY2024 Annual Earnings on October 8, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.5399

NKGen Biotech Inc. and HekaBio K.K. Partner to Promote NK Cell Therapy in Japan

NKGen Biotech Secures $2 Million from Japanese Investors

NKGen Biotech Announces Company Update

NKGen Biotech Launches Expanded Alzheimer's Clinical Trial

Nkgen Biotech Completes Acquisition of NKMAX

NKGen Biotech Delays Submission of 2025 Q1 Financial Report

NKGen Biotech CEO funds Alzheimer's clinical trial

Nkgen Biotech Issued 2,593,775 Shares to Kepos

NKGen Biotech released FY2024 Q3 earnings on March 4, 2025 (EST), with actual revenue of 0 USD and EPS of 0.1525 USD

NKGen Biotech released FY2024 9 Months Earnings on March 4, 2025 (EST), with actual revenue of 0 USD and EPS of -0.7584 USD

NKGen Biotech Administers Troculeucel to Stroke Patients Under FDA-Approved Compassionate Use Program

NKGen Biotech Receives Notice from Nasdaq

NKGen Biotech receives notice from NASDAQ regarding violation of listing rules

NKGen Biotech to Present Clinical Data on Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapy Summit

NKGen's SNK01 NK Cell Therapy Approved for Phase II Clinical Trials in Alzheimer's Disease

NKGen Biotech to Showcase Autologous NK Cell Therapy at the 5th International Cell and Gene Therapy China Summit

Nkgen Biotech Secures $5 Million Funding to Advance Clinical Projects

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap